Authors: Wood, A Trainor, G Rothwell, J Moore, A Harrington, R

Citation: A. Wood et al., Randomized trial of group therapy for repeated deliberate self-harm in adolescents, J AM A CHIL, 40(11), 2001, pp. 1246-1253

Authors: Kaltenbach, RF Trainor, G Getman, D Harris, G Garber, S Cordova, B Bacheler, L Jeffrey, S Logue, K Cawood, P Klabe, R Diamond, S Davies, M Saye, J Jona, J Erickson-Viitanen, S

Citation: Rf. Kaltenbach et al., DPC 681 and DPC 684: Potent, selective inhibitors of human immunodeficiency virus protease active against clinically relevant mutant variants, ANTIM AG CH, 45(11), 2001, pp. 3021-3028

Authors: Trainor, G

Citation: G. Trainor, Readers praise new journal, J AM WATER, 93(1), 2001, pp. 8-8

Authors: Gilligan, PJ Baldauf, C Cocuzza, A Chidester, D Zaczek, R Fitzgerald, LW McElroy, J Smith, MA Shen, HSL Saye, JA Christ, D Trainor, G Robertson, DW Hartig, P

Citation: Pj. Gilligan et al., The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-alpha]-pyrimidine: A corticotropin-releasing factor (hCRF(1)) antagonist, BIO MED CH, 8(1), 2000, pp. 181-189

Authors: He, LQ Gilligan, PJ Zaczek, R Fitzgerald, LW McElroy, J Shen, HSL Saye, JA Kalin, NH Shelton, S Christ, D Trainor, G Hartig, P

Citation: Lq. He et al., 4-(1,3-dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2,4-dichlorophenyl)-pyrazolo[1,5-a]-1,3,5-triazine: A portent, orally bioavailable CRF1 receptor antagonist, J MED CHEM, 43(3), 2000, pp. 449-456

Authors: LoRusso, PM Parchment, R Demchik, L Knight, J Polin, L Dzubow, J Behrens, C Harrison, B Trainor, G Corbett, TH

Citation: Pm. Lorusso et al., Preclinical antitumor activity of XK469 (NSC 656889), INV NEW DR, 16(4), 1998, pp. 287-296